<div><div>On December 3, 2025, Sonnet BioTherapeutics Holdings, Inc. announced the resignation of several board members and executives following a business combination. The changes were effective immediately.<div><table><tbody><tr><td>Individual</td><td>Donald Griffith</td><td>Nailesh Bhatt</td><td>Albert Dyrness</td><td>Lori McNeill</td><td>John K. Cini</td><td>Susan Dexter</td><td>Richard Kenney</td><td>Stephen McAndrew</td></tr><tr><td>Role</td><td>Director, CFO</td><td>Director</td><td>Director</td><td>Director</td><td>Chief Scientific Officer</td><td>Chief Technical Officer</td><td>Chief Medical Officer</td><td>President and Chief Business Officer</td></tr><tr><td>Type of Change</td><td>Resigned</td><td>Resigned</td><td>Resigned</td><td>Resigned</td><td>Resigned</td><td>Resigned</td><td>Resigned</td><td>Resigned</td></tr><tr><td>Effective Date</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td><td>Effective Time</td></tr><tr><td>Reason</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td><td>Business Combination</td></tr><tr><td>Replacement Info</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr><tr><td>Background Details</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>Board/Committee Role Changes</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr></tbody></table></div>Original SEC Filing: Sonnet BioTherapeutics Holdings, Inc. [ SONN ] - 8-K - Dec. 03, 2025<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

SONN

Sonnet BioTherapeutics Holdings, Inc. announced the resignation of several board members and executives effective December 3, 2025, following a business combination. The individuals who resigned include Donald Griffith (Director, CFO), Nailesh Bhatt (Director), Albert Dyrness (Director), Lori McNeill (Director), John K. Cini (Chief Scientific Officer), Susan Dexter (Chief Technical Officer), Richard Kenney (Chief Medical Officer), and Stephen McAndrew (President and Chief Business Officer). Replacement information and board/committee role changes were not disclosed.

Sonnet BioTherapeutics Announces Board and Executive Resignations